Thursday, May 19, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Serum Institute Applies To Dcgi To Manufacture Sputnik V Vaccine

Serum Institute applies to DCGI to manufacture Sputnik V vaccine

By PTI
Published: Published Date - 11:46 AM, Thu - 3 June 21
Representational Image. The Pune-based firm has also sought approval for test analysis and examination.

 New Delhi: The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, sources said on Thursday.

The Pune-based firm has also sought approval for test analysis and examination.

Russia’s Sputnik V vaccine is currently being manufactured in India by Dr Reddy’s Laboratories.
“The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India,” a source said.

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.

The vaccine was given emergency use authorisation (EUA) by the DCGI in April.

A consignment of 30 lakh doses of Sputnik V landed in Hyderabad on Tuesday.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • Drug Controller General of India (DCGI)
  • Serum Institute of India (SII)
  • Sputnik V vaccine

Related News

  • SEC to hold meeting on Bharat Biotech’s Nasal vaccine booster dose

  • Hetero gets DCGI nod for molnupiravir to treat high-risk Covid-19 patients

  • WHO approves emergency use of Covovax

  • Opinion: Vaccinate the world with India

  • Vaccine must not be entry barrier for nations: Bharat Biotech

  • Dr Reddy’s to strengthen commercial roll-out of Sputnik V in coming weeks

Latest News

  • CM KCR embarks on ‘national mission’

    4 hours ago
  • I want to dedicate this victory to all Indians: Telangana’s Nikhat Zareen

    4 hours ago
  • Opinion: Life within Dark Media

    4 hours ago
  • Editorial: Go beyond optics

    4 hours ago
  • Working women face accommodation problem in Hyderabad

    4 hours ago
  • 17.89 lakh acres to be cultivated in erstwhile Warangal

    4 hours ago
  • ‘Credibility’ crisis hits Almas Global

    4 hours ago
  • 15-year-old Hyderabadi encourages students to use old textbooks to save trees

    5 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam